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Abstract 
 It is well known that osteopenia and osteoporosis are frequently found celiac disease 
patients presenting classical symptoms of malabsorption1. Osteomalacia cases have also been 
diagnosed in celiac patients who do not present clinical signs of malabsorption , in patients 
with latent celiac disease, as well as in first degree relatives of patients with celiac disease 
who do not suffer from celiac disease themselves. This suggests the presence of different 
pathogenic mechanisms2. The analysis of genetic polymorphism represents an effective 
approach for an in-depth screening of genes potentially implicated in the development of 
osteoporosis.  
Because of the central role that estrogen plays in bone metabolism, ER genes play an 
important role in the determination of bone mineral density and the risk of osteoporosis. The 
fact that osteoporotic phenotypes are observed in patients with a destructive mutation of the α 
receptor gene for estrogen together with the signs of reduced bone mineral density that are 
found in mice presenting a functional insufficiency of ER α, but not in mice showing reduced 
ER β function, demonstrates that ER α is one of the principal genes involved in the genesis of 
osteoporosis3. 
Previously , two intronic polymorphisms of the α ER gene, identified by restriction 
endonucleases PvuII and TA Xba and repetitive polymorphism sequences, have been linked 
to bone mass density in the Japanese population and in menopausal Italian women4. 
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Introduction 
 It is well known that osteopenia and osteoporosis are frequently found celiac disease 
patients presenting classical symptoms of malabsorption1. Osteomalacia cases have also been 
diagnosed in celiac patients who do not present clinical signs of malabsorption, in patients 
with latent celiac disease, as well as in first degree relatives of patients with celiac disease 
who do not suffer from celiac disease themselves. This suggests the presence of different 
pathogenic mechanisms2. The analysis of genetic polymorphism represents an effective 
approach for an in-depth screening of genes potentially implicated in the development of 
osteoporosis.  
 Because of the central role that estrogen plays in bone metabolism, ER genes play an 
important role in the determination of bone mineral density and the risk of osteoporosis. 
 
Objective 
 Evaluate the genotypic distribution of two intronic polymorphisms, PvuII and Xba1, 
of the α ER receptor gene in a group of celiac disease patients. Study the correlation between  
particular bone structure and the corresponding genotype in celiac patients, divided into three 
groups based on their BMD (normal, osteopenia, osteoporosis). 
 
Case Studies  
 Patients: 80 celiac disease patients between 23 and 74 years of age (mean ± SD = 44.7 
± 1.5). Control: 156 healthy patients (no celiac disease), post-menopausal women between 43 
and 75 years of age   (mean ± SD = 63.6 ± 0.6). 
 
Methods  
 Celiac Disease Diagnosis: Dosage of AGA IgA, IgG, TTGA (Eurospital, Trieste), 
EMA (Euroimmun, Poyesis, Padoue), quantitative immunoglobulin. 
Histological exams of biopsies of the second and third part of the duodenum taken during 
endoscopy. 
 Laboratory Tests: Parameters of intestinal absorptions of antibodies, some indicators 
of bone remodeling, and BMD of the entire body.  
Table1.Turnover Markers and Bone Resorption Parameters of Celiac Disease Patients. 
Parameters Normal Values 
Serum Calcium 8.8-10.7mg/dl 
24 hours Urine Calcium 100-300mg/24h 
Phosphorus 2.5-5.0mg/dl 
Phosphaturia 400-1000/24h 
Serum Magnesium 1.8-2.6mg/dl 
Parathyroid PTH 10-70p g/ml 
Osteocalcin U 4.4-12.8; D 3.2-16.8 
Total Alkaline Phosphatase 60-270 U/I 
Bone Alkaline Phosphatase U 3.7-22; D 3.4-20 ng/ml 
Urinary D-pyridinoline 2.0-9 nM/Mm Creat. 
Vitamin D 25-OH 5.51 Winter; 56.8 Summer 
Vitamin D 1-25 (OH)2 20.6-70.8 pg/ml 
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 Evaluation of Bone Mineral Density: Bone mineral density (BMD) was measured in 
all patients by computerized bone mineralometry (OMC) with a total body DEXA 
densitometer (Dual Energy X-ray absorptiometry) Hologic QDR-1000. 
BMD absolute value was established with a Z-score and a T-score in accordance to WHO 
classification system. 
Table2. WHO T-Score Values 
Normal osteopenia Osteoporosis 
0<T-score<-1 SD -1<T-score<-2.5 SD T-score<-2.5 SD 
 
Genotyping 
 DNA was extracted by the standard procedure with phenol/chloroform and then 
amplified in 50 µL buffer solution using 1 unit of Taq Polymerase (Promega, Madison WI) 
and 0,4 µM of oligonucleotidic primers direction 5'-3‘ and opposite direction 5‘-3' using 30 
cycles of polymerase chain reaction (PCR) to obtain a part of the intron 1 and exon 2 of the α 
ER gene. The product of amplification was digested by 10 units of restriction enzyme XbaI or 
PvuII and subjected to electrophoresis on 2% Agarose Gel. 
 The presence of the restriction site for each endonuclease was conventionally 
indicated with lowercase letters p and x, whereas the absence of the restriction site was 
indicated with capital letters P and X respectively for PvuII and Xba1. Based on the model of 
digestion of the PCR product, patients were identified as homozygous pp, xx, PP or XX or 
heterozygous Pp or Xx. 
Fig1.Electrophoresis on 2% Agarose Gel of the Product of Digestion for the α ER Gene Xba1 & PvuIl 
 
Statistical Analysis  
The test χ squared was used to compare the polymorphism distribution of the α ER gene in 
CD patients and controls. The Fisher test was used to evaluate the difference between the 
frequency of both polymorphisms in the three groups: normal, osteopenia, osteoporosis.  
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Fig2.Genotypic Distribution of Xba1 and PvuII Analyzed Separately for Patients and Controls  
   
  P>0.05     p>0.05 
Fig3.Genotypic Distribution of Xba1 and PvuII in Combined Analysis for CD Patients and Controls 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results  
 
 
 
 
Fig4.Genotypic Distribution of Xba1 and PvuII analyzed Separately for the Three Groups of CD Patients 
 
 
     
  
   
 
 
   P>0.05 
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Fig5.Genotypic Distribution of Xba1 and PvuII Analyzed in Combination for the Three Groups of CD Patients  
P>0.05 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52/80 patients (65%) were diagnosed with osteoporosis or osteopenia. 
31/80 osteopenia 
21/80 osteoporosis  
28/80 normal 
 
 No significant differences were found between the three different genotypes in either 
analysis of the three CD groups (normal, osteopenia, osteoporosis) in both analysis: 
Separately and in combination for restriction sites. 
 
Conclusion  
 There is a high prevalence of alterations in bone mineral density in celiac disease. 
There are significant differences between the genotypic distributions of the two 
polymorphisms for the CD patient group versus the control group. No significant difference 
was observed in the two genotypic distributions for the three groups of CD patients. The three 
genotypes PPxx, ppXx and ppXX are found ONLY in CD patients suffering from osteopenia 
or osteoporosis. 
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